Literature DB >> 28731334

Optical Spectra and Magnetic Behavior of a Wide Range of Europium(III) Oxo-Compounds: Analysis of the Ligand-Field Effects.

Anna Bronova1, Nils Kannengießer1, Robert Glaum1.   

Abstract

The europium-oxygen interaction in nine different europium(III) oxo-compounds (including C-type Eu2O3) was investigated on the basis of powder reflectance spectra (near-IR/vis/UV) and temperature-dependent magnetic measurements. Computation of the transition energies and of the effective Bohr magneton numbers for Eu3+ in the different ligand fields were performed within the framework of the angular overlap model (AOM) using the computer program BonnMag. These calculations show that all electronic transition energies in the optical spectra, the magnetic susceptibilities as well as their temperature dependence, are very well-accounted for by AOM. BonnMag provides a facile way to perform these calculations. Analysis of the obtained "best fit" AOM parameters eσ(EuIII-O) shows that these are significantly influenced by the further bonding partners of oxygen ("second-sphere ligand-field effect"). An increase of eσ, max(EuIII-O) from 404 cm-1 (EuPO4) to 687 cm-1 (EuSbO4), both normalized to d(EuIII-O) = 2.38 Å, is found. Correlation of this variation to oxide polarizability and optical basicity of the oxo-compounds is discussed.

Entities:  

Year:  2017        PMID: 28731334     DOI: 10.1021/acs.inorgchem.7b01287

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  2 in total

1.  Slowing magnetic relaxation with open-shell diluents.

Authors:  Ian P Moseley; Christopher P Ard; Joseph A DiVerdi; Andrew Ozarowski; Hua Chen; Joseph M Zadrozny
Journal:  Cell Rep Phys Sci       Date:  2022-03-16

2.  Revisiting the Fundamental Nature of Metal-Ligand Bonding: An Impartial and Automated Fitting Procedure for Angular Overlap Model Parameters.

Authors:  Moritz Buchhorn; Robert J Deeth; Vera Krewald
Journal:  Chemistry       Date:  2022-02-02       Impact factor: 5.020

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.